Status:
RECRUITING
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Lead Sponsor:
Shengjing Hospital
Conditions:
Meningioma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This prospective single-center study aims to evaluate the feasibility and clinical utility of three-dimensional magnetic resonance elastography (3D MRE) in assessing tumor stiffness and adhesion in pa...
Detailed Description
Meningiomas are the most common primary intracranial tumors and are often surgically resectable. However, the intraoperative texture and adhesion of the tumor to surrounding structures vary widely and...
Eligibility Criteria
Inclusion
- All patients undergoing meningeoma resection surgery are eligible for inclusion in the study cohort.
Exclusion
- Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who can not remove dentures, insulin pumps, or contraceptive rings)
- Pregnant women in the first trimester (within three months)
- Patients with severe claustrophobia or anxiety
- Patients with severe fever
- Patients who can not tolerate MRE
- Patients with vascular malformations and aneurysms.
- Patients who do not sign an informed consent
Key Trial Info
Start Date :
October 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 9 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06955208
Start Date
October 19 2022
End Date
October 9 2026
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital
Shenyang, Liaoning, China, 110000